As per media reports, the regulator is learnt to have found deficiencies relating to medicine quality, data collection, maintenance as well as quality control unit
from Latest News http://bit.ly/2L29f3A
Thursday, 25 April 2019
USFDA issues Form 483 to Sun Pharma's Dadra plant over quality issues
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment